Enveric Biosciences Inc
enveric.comWhat Do They Do?
Develops small-molecule drug candidates intended to treat psychiatric and neurological disorders, including non-hallucinogenic compounds for mental health conditions.
10-K for FY2025, filed Mar 27, 2026
Sources
How Are They Changing?
Since the FY2025 annual report
Latest quarter: Q2 FY2026, the three months to Jun 30, 2026
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 14, 2026
−$3MView ↗
- ▲ +20% (Loss)
- vs −$2.5M in Q2 FY2025
Loading...
Comments
